KRAS and head and neck squamous cell carcinoma: In addition to point mutations and stimulation with receptor ligands, exposure to a clinically relevant dose of IR rapidly activates K-Ras in KRAS wild-type head and neck squamous cell carcinoma FaDu cells [10].